The Effects of Treatment With Sertraline for Noncardiac Chest Pain

• Status: Completed
• Trial end date: 2002-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether care as usual or intervention (consisting of sertraline versus placebo), are effective in the treatment of panic disorder and/or depression driven noncardiac chest pain.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Maastricht University Medical Center
• Collaborator: Pfizer
• Treatments: Sertraline

Criteria

Inclusion Criteria:

• chest pain without a cardiac cause

• diagnosed with panic disorder and or depression according to Diagnostic and statistical Manual (DSM) IV criteria

• Living < 50 km from the hospital

• informed consent

Exclusion Criteria:

• other primary DSM IV diagnosis

• known sensitivity to sertraline

• using other anti-depressive agents

• not speaking dutch language

• living in a nursery home or having dementia

• other severe, acute or progressive disease, kidney or liver-function disturbances, pregnancy or breastfeeding